Treatment of status migrainosus

Bibliography

• BIGAL M, BORDINI CA, SPECIALI JG: Headache in anemergency room in Brazil. Sao Paulo Med. J. (2000) 118:58–62.
   PubMedGoogle Scholar
• ANTHONY M, HINTERBERGER H, LANCE JW: Plasmaserotonin in migraine and stress. Arch. Neurol. (1967) 16:544–552.
   PubMedGoogle Scholar
• KIMBALL RW, FRIEDMAN AP, VALLEJO E: Effect ofserotonin in migraine patients. Neurology (1960) 10:107–111.
   PubMed Web of Science ®Google Scholar
• GOADSBY PJ, LANCE JW: Physiopathology of migraine.Revue du Praticien (1990) 40:389–393.
   PubMedGoogle Scholar
• MARCUS DA: Serotonin and its role in headachepathogenesis and treatment. Clin. J. Pain (1993) 9:159–167.
   PubMedGoogle Scholar
• •This review describes a model for the role of 5-HT in migraine that incorporates both experimental and clinical data.
   Google Scholar
• SANDERS-BUSH E, BREEDING M, KNOTH K, TSUTSUMI M: Sertraline-induced desensitzation of the serotonin 5HT-2 receptor transmembrane signaling system. Psychopharmacology (Berl) (1989) 99:64–69.
   PubMedGoogle Scholar
• PAPP M, KLIMEK V, WILLNER P: Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression. Psychophar-macology (Berl) (1994) 144 :309–314.
   Google Scholar
• MATHEW RC, HO BT, KRALIK P, CLAGHORN JL: Biochemical basis for biofeedback treatment of migraine: a hypothesis. Headache (1979) 19:290–293.
   PubMed Web of Science ®Google Scholar
• SILBERSTEIN SD: Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review). Neurology (2000) 55:754–763.
   PubMed Web of Science ®Google Scholar
• ••A comprehensive review of recommendations for thetreatment of migraine.
   Google Scholar
• TFELT-HANSEN P, SAXENA PR, DAHLOF C et al.: Ergota- mine in the acute treatment of migraine: a review and European consensus. Brain (2000) 123:9–18.
   PubMed Web of Science ®Google Scholar
• •European consensus statement on acute management of migraine.
   Google Scholar
• MOORE KH, HUSSEY EK, SHAW S et al.: Safety, tolerability and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses. Cephalalgia (1997) 17:541–550.
   PubMed Web of Science ®Google Scholar
• Presentations European Neurological Society Meeting.Lisbon, Portugal (1999).
   Google Scholar
• CABARROCAS X, SALVA M: Pharmacokinetic andmetabolic data on almotriptan, a new migraine drug. Cephalalgia (1997) 17:422.
   Google Scholar
• SPIERINGS EL, GOMEZ-MANCILLA B, GROSZ DE et al.:Oral almotriptan vs. oral sumatriptan in a double-blind, randomized, parallel-group study in migraine patients. Headache (2000) 40:433.
   Google Scholar
• WINNER P, RICALDE O, LEFORCE B et al.: A double-blindstudy of sc. dihydroergotamine versus sc. sumatip tan in the treatment of acute migraine. Arch. Neurol. (1996) 53:180–184.
   Google Scholar
• KRYMCHANTOWSKI AV: Naprox en sodium decreasesrecurrence when used with sumatriptan. Headache Quarterly (1999) 10:297–299.
   Google Scholar
• KRYMCHANTOWSKI AV, ADRIANO M, FERNANDES D: Tolfenamic acid decreases migraine recurrence when used with sumatriptan. Cephalalgia (1999) 19:186–187.
   PubMed Web of Science ®Google Scholar
• KLAPPER JA, STANTON J: Clinical experience withpatient administered subcutaneous dihyddroergota-mine mesylate in refractory headaches. Headache (1992) 32:21–23.
   PubMedGoogle Scholar
• DAHLOF C, BOUCHARD J, CORTELLI P et al.: A multina-tional investigation of the impact of subcutaneous sumatriptan. II: Health-related quality of life. Pharma-coeconomics (1997) 11 (Suppl. 1):24–34.
   Google Scholar
• LOFLAND JH, JOHNSON NE, BATENHORST AJ, NASH DB: Changes in resource use and outcome for patients with migraine treated with sumatriptan: a managed care perspective. Arch. Int. Med. (1999) 159:857–868.
   PubMed Web of Science ®Google Scholar
• ••A study of the economic impact of sumatriptan administeredto a community-based sample of migraineurs.
   Google Scholar
• COHEN JA, BEALL DG, MILLER DW et al.: Subcutaneous sumatriptan for the treatment of migraine: humanistic, economic, and clinical consequences. Fam. Med. (1996) 28:171–177.
   PubMedGoogle Scholar
• LEGG RF, SCLAR DA, NEMEC NL et al.: Cost-effectiveness of sumatriptan in a managed care population. Am. J Manag. Care (1997) 3:117–122.
   PubMedGoogle Scholar
• COHEN JA, BEALL D, BECK A et al.: Sumatrip tan treatment for migraine in a health maintenance organization: economic, humanistic, and clinical outcomes. Clin. Ther. (1999) 21:190–204.
   PubMed Web of Science ®Google Scholar
• BIDDLE AK, SHIH YC, KWONG WJ: Cost-benefit analysis of sumatriptan tablets versus usual therapy for treatment of migraine. Pharmacotherapy (2000) 20:1356–1364.
   PubMed Web of Science ®Google Scholar
• GAIST D, TSIROPOULOS I, SINDRUP SH et al.: Inappro-priate use of sumatriptan: population based register and interview study. Br. Med. J (1998) 16:1352–1353.
   Google Scholar
• GOADSBY PJ: Sumatrip tan is not the only analgesic used inappropriately. Br. Med. J. (1998) 317:1016.
   PubMedGoogle Scholar
• GOLDFARB SD, DUNCAN BS, DANS PE, SLOAN AS: HMOdirect cots and health care resources use after implementation of a monthly limit on sumatriptan. Am. J. Health Syst. Pharm. (1999) 56:2206–2210.
   PubMedGoogle Scholar
• PETERS BH, FRAIM CJ, MASEL BE: Comparison of 650 mg aspirin and 1,000 mg acetaminophen with each other and with placebo in moderately severe headache. Am. J. Med. (1983) 76:36–42.
   Google Scholar
• BOUREAU F, JOUBERT JM, LASSERE V, PRUM B, DELECOEIULLERIE G: Double-blind comparison of an acetaminophen 400 mg-codiene 25 mg combination versus aspirin 1000 mg and placebo in acute migraine attack. Cephalagia (1994) 1 4 :156–161.
   Google Scholar
• HAMALAINEN ML, HOPPU K, VALKEILA E, SANTAVUORI P: Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology (1997) 48:103–107.
   PubMed Web of Science ®Google Scholar
• DALESSIO DJ: Caffeine as an analgesic adjuvant: review of the evidence. Headache (1994) 34 (Suppl. 0:10–12.
   Google Scholar
• FORBES JA, BEAVER WT, JONES KF et al.: Effect of caffeine on ibuprofen analgesic in postoperative oral surgery pain. Clin. Pharmacol. Ther. (1991) 49:674–684.
   PubMed Web of Science ®Google Scholar
• LIPTON R, STEWART WF, RYAN RE, Jr., SAPER J, SILBER-STEIN S, SHEFTELL F: Efficacy and safety of acetamino-phen, aspirin, and caffeine in alleviating migraine headache pain: 3 double-blind, randomized, placebo-controlled trials. Arch. Neurology (1998) 55:210–217.
   PubMed Web of Science ®Google Scholar
• JONES EB, GONZALEZ ER, BOGGS JG, GRILLO JA, ELSWICK RK: Safety and efficacy of rectal prochlor-perazine for the treatment of migraine in the emergency department. Ann. Emerg. Med. (1994) 24:237–241.
   PubMed Web of Science ®Google Scholar
• COPPOLA M, YEALY DM, LEIBOLD RA: Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann. Emerg. Med. (1995) 26:541–546.
   PubMed Web of Science ®Google Scholar
• SEIM MB, MARCH JA, DUNN KA: Intravenous ketorolacversus intravenous prochloperaine for the treatment of migraine headache. Acad. Emerg. Med. (1998) 5:573–576.
   PubMed Web of Science ®Google Scholar
• JONES J, PACK S, CHUN E: Intramuscular prochlopera-zinc versus metochlopramide as single agent therapy for the treatment of acute migraine headache. Am. J. Emerg. Med. (1996) 14:262–264.
   PubMed Web of Science ®Google Scholar
• VON SEGGERN RL, ADELMAN JU: Practice and economics cost considerations in headache treatment. Part 2: acute migraine treatment. Headache (1996) 36:493–502.
   Google Scholar
• SAADAH HA: Abortive migraine therapy in the office with dexamethasone and prochlorperazine. Headache (1994) 34:366–370.
   PubMed Web of Science ®Google Scholar
• DIENER HC (ASASUMAMIG STUDY GROUP): Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. Cephalalgia (1999) 19 :581–588 .
   Google Scholar